 |
|
|
| |
RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/r + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION
|
| |
| |
Reported by Jules Levin
EASL - 11 April 2014 - 49th Annual Meeting of the European Association for the Study of the Liver, London, United Kingdom
Christophe Hezode, Patrick Marcellin, Stanislas Pol, Tarek Hassanein, Katarzyna Fleischer-Stepniewska, Tolga Baykal, Tianli Wang, Sandra S. Lovell, Tami Pilot-Matias, Regis A. Vilchez
|
| |
|
|
|
|
|
